Literature DB >> 25195931

Continuous renal replacement therapy during extracorporeal membrane oxygenation in patients treated in medical intensive care unit: technical considerations.

Bożena Seczyńska1, Wiesław Królikowski, Ilona Nowak, Miłosz Jankowski, Konstanty Szułdrzyński, Wojciech Szczeklik.   

Abstract

Extracorporeal membrane oxygenation (ECMO) is used as a salvage therapy in refractory acute respiratory distress syndrome (ARDS). Although technological progress in the ECMO systems improved the survival rate, prognosis is still significantly worsened by acute kidney injury (AKI), particularly if renal replacement therapy (RRT) is required. There are no exact guidelines recommending which techniques of ECMO and continuous RRT (CRRT) should be used for management of AKI coexisting with respiratory or circulatory failure, and how to combine them. The aim of this review is to describe methods of CRRT and ECMO simultaneous application, and to present advantages of various technical approaches versus possible complications.
© 2014 The Authors. Therapeutic Apheresis and Dialysis © 2014 International Society for Apheresis.

Entities:  

Keywords:  Acute kidney injury; Acute respiratory distress syndrome; Continuous renal replacement therapy; Extracorporeal membrane oxygenation; Methods

Mesh:

Year:  2014        PMID: 25195931     DOI: 10.1111/1744-9987.12188

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  13 in total

1.  A safe procedure for connecting a continuous renal replacement therapy device into an extracorporeal membrane oxygenation circuit.

Authors:  Natsumi Suga; Yosuke Matsumura; Ryuzo Abe; Noriyuki Hattori; Taka-Aki Nakada; Shigeto Oda
Journal:  J Artif Organs       Date:  2017-03-24       Impact factor: 1.731

2.  Aquapheresis (AQ) in Tandem with Extracorporeal Membrane Oxygenation (ECMO) in Pediatric Patients.

Authors:  Alex R Constantinescu; Jason L Adler; Eileen Watkins; Xamayta L Negroni-Balasquide; De'Ann Laufenberg; Frank G Scholl; Gerald J Lavandosky
Journal:  J Extra Corpor Technol       Date:  2019-09

3.  Extracorporeal Membrane Oxygenation and the Kidney.

Authors:  Gianluca Villa; Nevin Katz; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2015-10-17       Impact factor: 2.041

Review 4.  Renal replacement therapy during extracorporeal membrane oxygenation.

Authors:  Balasubramanian Subbarayan; Vadamalai Vivek; Madhan Kumar Kuppuswamy
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2020-01-29

Review 5.  Continuous renal replacement therapy in patients treated with extracorporeal membrane oxygenation.

Authors:  David T Selewski; Keith M Wille
Journal:  Semin Dial       Date:  2021-03-25       Impact factor: 2.886

6.  Extracorporeal membrane oxygenation combined with continuous renal replacement therapy in cutaneous burn and inhalation injury caused by hydrofluoric acid and nitric acid.

Authors:  Qinhua Pu; Jinxian Qian; Weiyi Tao; Aixiang Yang; Jian Wu; Yaodong Wang
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

7.  Using additional pressure control lines when connecting a continuous renal replacement therapy device to an extracorporeal membrane oxygenation circuit.

Authors:  Soo Jin Na; Hee Jung Choi; Chi Ryang Chung; Yang Hyun Cho; Hye Ryoun Jang; Gee Young Suh; Kyeongman Jeon
Journal:  BMC Nephrol       Date:  2018-12-19       Impact factor: 2.388

8.  Retrospective study on the effects of the prognosis of patients treated with extracorporeal membrane oxygenation combined with continuous renal replacement therapy.

Authors:  Ping He; Shixin Zhang; Bingyang Hu; Wei Wu
Journal:  Ann Transl Med       Date:  2018-12

9.  How to do it: Plasmapheresis via venoarterial extracorporeal membrane oxygenation circuit for thyroid storm.

Authors:  Lucy Manuel; Laura S Fong; Andrew Lahanas; Peter Grant
Journal:  Ann Med Surg (Lond)       Date:  2021-06-10

10.  Impact of an inline extracorporeal membrane oxygenation hemofilter system in neonatal acute kidney injury.

Authors:  Mohammed Azar; Abdulrahman Alamir; Abdullah Thabet Al Qahtani; Al Mokali Khamisa; Khalid Alfakeeh
Journal:  Ther Clin Risk Manag       Date:  2018-05-01       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.